Company

WaveBreak

Biotechnology Research Boston, Massachusetts, United States 13 employees

Employees: 13
Contacts: 3
Emails: 3
Phones: 2

wrentherapeutics.com LinkedIn

WaveBreak Overview

Headquarters: Boston, Massachusetts, United States
Website: wrentherapeutics.com
Industry: Biotechnology Research
Employees: 13
Founded: 2016
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

About WaveBreak

WaveBreak is a biopharmaceutical company focused on transforming drug discovery for neurodegenerative diseases, targeting the fleeting protein intermediates central to many disease pathways that are beyond the reach of conventional drug discovery approaches. WaveBreak has built a unique drug discovery platform to target the transient protein intermediates—the oligomers—in these disease pathways, to interrupt the molecular mechanisms that are the source of oligomer generation with small-molecule therapeutics. WaveBreak is focusing this platform first on some of the greatest unmet medical needs of our time: Parkinson’s disease, Lewy body dementia, Alzheimer’s disease, and ALS.

WaveBreak Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 2; 50.0% coverage

WaveBreak Org Chart

Sample employees and titles

Name	Title	Location	Contact
Michele Vendruscolo	Professor at University of Cambridge	Greater Cambridge Area, United Kingdom	Email
Glen Roesch	.	East Islip, New York, United States	Email Phone
Bart Henderson	CEO, President Wavebreak	Boston, Massachusetts, United States	Email Phone
Sarah Ball	Principal Scientist & Consultant at Wavebreak Therapeutics Llc - R&D Strategy & Innovation	Sydney, New South Wales, Australia	View